Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Jacqueline Zummo

Chief R&D Officer at Protara Therapeutics, Inc. (TARA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $125K

Reported trades

Filed Stock Type Shares Price Value Since
Apr 9SEC TARAProtara Therapeutics, Inc. Sell Plan 1,13494,827 held (−1%) $5.40 $6K -57.0%
Apr 2SEC TARAProtara Therapeutics, Inc. Sell Plan 22,59895,961 held (−19%) $5.26 $119K -55.9%
  • Sell

    Chief R&D Officer Jacqueline Zummo sold $6K of TARA at $5.40 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief R&D Officer Jacqueline Zummo sold $119K of TARA at $5.26 — pre-scheduled 10b5-1 plan sale.